| Bioactivity | Relzomostat is a methionine aminopeptidase 2 (MetAP2) inhibitor.Relzomostat may be useful for the research of obesity, type 2 diabetes, and other obesity-associated conditions[1]. |
| Name | Relzomostat |
| CAS | 2081078-92-2 |
| Formula | C24H36F2N2O5 |
| Molar Mass | 470.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zahler, Robert; Vath, James E. Preparation of fumagillol spirocyclic and fused bicyclic compounds and their use as MetAP2 inhibitors. WO2017027687A1 |
Relzomostat
CAS: 2081078-92-2 F: C24H36F2N2O5 W: 470.55
Relzomostat is a methionine aminopeptidase 2 (MetAP2) inhibitor.Relzomostat may be useful for the research of obesity, t
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.